Sandra Sánchez y Oldenhage is a Biopharmaceutical Specialist with 34 years of executive level experience in top ranked multinational companies including Merck Sharp & Dohme, Pfizer, and Novartis where she was responsible for the Latin America region. She was also President & General Manager for Amgen and Biogen, successfully establishing and growing both companies in Mexico.

During her career, she has successfully launched and established Startups, implemented turnaround strategic endeavors, driving growth within mature organizations across multiple functional areas.

Sandra is named as one of the top 50 most powerful businesswomen in Mexico by renowned business magazine CNN EXPANSION from 2006 to date, and Forbes Magazine from 2014 – 2021. She was also named as one of Pharma Exec’s 17 Emerging Pharma Leaders in 2015. Moreover, she was one of 21 global executives selected by the International Women’s Foundation (IWF) to participate in their elite Fellows Program from 2008-2010. This highly selective program trains and develops top businesswomen from all over the world in entrepreneurial leadership, global administration, and mentoring, at universities including Harvard and Cambridge.